Zypitamag
4 mg · Tablet, Film Coated
- Prescription only
- HMG-CoA Reductase Inhibitor
- Active substance
- Pitavastatin Magnesium
- Made by
- Medicure International Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Pitavastatin). It describes the substance, not this exact product.
Pitavastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, a rate-limiting step in the biosynthetic pathway for cholesterol.
As a result, the expression of LDL-receptors followed by the uptake of LDL from blood to liver is accelerated and then the plasma TC decreases.
The principal route of pitavastatin metabolism is glucuronidation via liver uridine 5'-diphosphate glucuronosyltransferase (UGT) with subsequent formation of pitavastatin lactone.
A mean of 15% of radioactivity of orally administered, single 32 mg 14 C-labeled pitavastatin dose was excreted in urine, whereas a mean of 79% of the dose was excreted in feces within 7 days.
Effect of Food Administration of pitavastatin tablets with a high fat meal (50% fat content) decreases pitavastatin C max by 43% but does not significantly reduce pitavastatin AUC.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-17
Safety of the active substance
From the US prescribing label for the same active substance (Pitavastatin). It describes the substance, not this exact product.
- Pitavastatin tablets is contraindicated in the following conditions: Concomitant use of cyclosporine [see Drug Interactions (7) ].
- Acute liver failure or decompensated cirrhosis [see Warnings and Precautions (5.3) ].
- Hypersensitivity to pitavastatin or any excipients in pitavastatin tablets.
- Hypersensitivity reactions including angioedema, rash, pruritus, and urticaria have been reported with pitavastatin tablets [see Adverse Reactions (6) ].
The most frequent adverse reactions (rate ≥ 2%) were myalgia, constipation, diarrhea, back pain, and pain in extremity.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Details
| Made by | Medicure International Inc |
|---|---|
| Active substance | Pitavastatin Magnesium |
| Used in | Heart, blood pressure and circulation |
| Strength | 4 mg |
| Form | Tablet, Film Coated |
| Route | Oral |
| Packs | 90 TABLET, FILM COATED in 1 BOTTLE · 500 TABLET, FILM COATED in 1 BOTTLE |
| NDC | 25208-202 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet, Film Coated4 products
2 mg2
2 mg · 2 companies
4 mg2
4 mg · 2 companies
- Medicure International Inc · this page
- Zydus Lifesciences Limited
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.